Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Digital Health Leader Verana Health Secures $150M Series E Funding Round
Verana Health, a digital health company that delivers quality drug lifecycle and medical practice insights […]
Aristea Therapeutics Announces Key Leadership Appointments to Advance its Clinical Pipeline
Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company advancing novel therapies to treat […]
BICO Partners with the Center for Contemporary Sciences (CCS) to Reduce Animal Testing in Life Sciences
Today BICO, a leading bio convergence company, announced a partnership with the Center for Contemporary […]
Insightful Science Acquires Omiq to Add Cloud-Based Machine Learning to its Flow Cytometry Capabilities
Insightful Science, the software company enabling the Cloud for Scientific Discovery, announced today that it […]
GenomOncology Pathology Workbench to Support OmniSeq INSIGHT℠, a Genomic and Immune Profiling Test That Identifies Potential Treatment and Clinical Trial Options for Solid Tumors
GenomOncology announced today that GenomOncology (GO) Pathology Workbench has been selected by Labcorp’s OmniSeq to […]
Arcensus has Appointed Prof. Dr. Arndt Rolfs as New CEO
Arcensus, a commercial-stage digital healthcare and diagnostics company that empowers people to take control of […]
Significant Investment Accelerates Freenome's Multiomics Platform for the Early Detection of Cancer
Freenome, a privately held biotech company, announced today that Roche has made an investment of $290 […]
NeoCura and PhoreMost Announce Research Collaboration to Explore Novel Cancer Therapeutics
NeoCura Bio-Medical Technology Co., Ltd. (“NeoCura”), a leading RNA-based drug research and development company in […]
Illumina and Boehringer Ingelheim Announce Companion Diagnostic Partnership
Illumina Inc. (NASDAQ: ILMN) today announced a partnership with Boehringer Ingelheim to develop companion diagnostics (CDx) […]
Fusion Pharmaceuticals Announces Nomination of First Targeted Alpha Therapy Candidate in Collaboration with AstraZeneca to Advance into IND-Enabling Studies for Phase 1 Development
Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more